Fundraising FoxSynfini
5 known investors
Find your way into Synfini
Sign up to see every warm intro you have to Synfini
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synfini team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Synfini provides AI-driven drug discovery collaboration services that help researchers advance targets and hits into optimized, patentable chemistry. The company offers a platform combining virtual screening, scaffold hopping, synthesis planning, and parallel library synthesis to accelerate early-stage drug discovery.
Founders & leadership
PM
Peter MadridScientific DevelopmentPeter Madrid served as Director of Discovery Technologies at SRI International, where he oversaw operations and strategy for a multidisciplinary research group. His background spans early-stage drug discovery, including target selection, lead optimization, and hit-to-lead identification, with prior NIH- and DoD-funded research on anti-infective and anti-cancer therapeutics.
NC
Nathan CollinsStrategic Alliance
JB
John ByrnesArtificial Intelligence
HO
Hillary OdgersFinance
Investors · 5
Foothill Ventures✓ confirmed by SynfiniLos Altos · $100K – $10M
How we know: the company's own site · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
__Twitter.png)
JSL Health CapitalreportedSarasota
How we know: funding news · Not right? Tell us
WERU Investment Co. Ltd.reportedTokyo
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Synfini do?
- Synfini provides AI-driven drug discovery collaboration services that help researchers advance targets and hits into optimized, patentable chemistry. The company offers a platform combining virtual screening, scaffold hopping, synthesis planning, and parallel library synthesis to accelerate early-stage drug discovery.
- Who are Synfini's investors?
- Synfini's investors include Foothill Ventures, Gaingels, Mana Ventures, JSL Health Capital, WERU Investment Co. Ltd..